Birdwatch Note
2024-04-17 04:09:14 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
動画最初のあたりの接種者の方がコロナ後遺症が続く何の統計的根拠も示されていない話者の感想に基づく噂話ですが 実際には、オミクロンの前は勿論のこと、オミクロン期に絞っても完全接種者はわずか(3割程度)に接種者は新型コロナウイルス感染後の症状が続くリスクが低かった事がメタアナリシスによりわかっています。 オミクロン期の結果は下記論文のtable 2の4つ目の項目です。 https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-systematic-literature-review-and-metaanalysis-of-the-latest-research/A0B115B5D3AA60846799857B801D116E 厚生労働省の研究班の19万人の住民の調査により感染前にワクチンを接種した人は接種していない人に比べて症状が続く割合がやや低かった事が発表されています↓ https://www3.nhk.or.jp/news/html/20230923/k10014204451000.html
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1780420981884133885
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1780448410614874451
- noteId - 1780448410614874451
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1713326954880
- tweetId - 1780420981884133885
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 動画最初のあたりの接種者の方がコロナ後遺症が続く何の統計的根拠も示されていない話者の感想に基づく噂話ですが 実際には、オミクロンの前は勿論のこと、オミクロン期に絞っても完全接種者はわずか(3割程度)に接種者は新型コロナウイルス感染後の症状が続くリスクが低かった事がメタアナリシスによりわかっています。 オミクロン期の結果は下記論文のtable 2の4つ目の項目です。 https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-systematic-literature-review-and-metaanalysis-of-the-latest-research/A0B115B5D3AA60846799857B801D116E 厚生労働省の研究班の19万人の住民の調査により感染前にワクチンを接種した人は接種していない人に比べて症状が続く割合がやや低かった事が発表されています↓ https://www3.nhk.or.jp/news/html/20230923/k10014204451000.html
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-17 04:09:14 UTC (1713326954880) |
2024-04-17 11:36:34 UTC (1713353794960) |
CURRENTLY_RATED_HELPFUL | 2024-04-18 01:52:12 UTC (1713405132780) |
NEEDS_MORE_RATINGS | 2024-04-17 11:36:34 UTC (1713353794960) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-17 09:16:33 -0500 | Rating Details | |
| 2024-04-17 08:12:01 -0500 | Rating Details | |
| 2024-04-17 07:26:38 -0500 | Rating Details | |
| 2024-04-17 05:57:00 -0500 | Rating Details | |
| 2024-04-17 05:12:02 -0500 | Rating Details | |
| 2024-04-17 04:44:39 -0500 | Rating Details | |
| 2024-04-17 04:25:54 -0500 | Rating Details | |
| 2024-04-17 04:15:35 -0500 | Rating Details | |
| 2024-04-17 03:10:29 -0500 | Rating Details | |
| 2024-04-17 02:43:48 -0500 | Rating Details | |
| 2024-04-17 01:54:07 -0500 | Rating Details | |
| 2024-04-17 01:43:57 -0500 | Rating Details | |
| 2024-04-17 00:57:04 -0500 | Rating Details | |
| 2024-04-17 00:45:26 -0500 | Rating Details | |
| 2024-04-17 00:39:50 -0500 | Rating Details | |
| 2024-04-17 00:36:48 -0500 | Rating Details | |
| 2024-04-17 00:28:00 -0500 | Rating Details | |
| 2024-04-17 00:03:57 -0500 | Rating Details | |
| 2024-04-16 23:58:04 -0500 | Rating Details | |
| 2024-04-16 23:52:00 -0500 | Rating Details | |
| 2024-04-16 23:46:00 -0500 | Rating Details | |
| 2024-04-16 23:37:31 -0500 | Rating Details | |
| 2024-04-16 23:17:45 -0500 | Rating Details | |
| 2024-04-18 07:47:00 -0500 | Rating Details | |
| 2024-04-17 09:29:32 -0500 | Rating Details | |
| 2024-04-17 07:53:50 -0500 | Rating Details | |
| 2024-04-17 06:28:31 -0500 | Rating Details | |
| 2024-04-17 05:43:20 -0500 | Rating Details | |
| 2024-04-17 03:23:02 -0500 | Rating Details | |
| 2024-04-17 03:12:32 -0500 | Rating Details | |
| 2024-04-17 02:34:36 -0500 | Rating Details | |
| 2024-04-17 01:47:38 -0500 | Rating Details | |
| 2024-04-17 01:30:28 -0500 | Rating Details | |
| 2024-04-17 00:57:17 -0500 | Rating Details | |
| 2024-04-17 00:11:37 -0500 | Rating Details | |
| 2024-04-17 00:05:28 -0500 | Rating Details | |
| 2024-04-16 23:58:20 -0500 | Rating Details | |
| 2024-04-16 23:55:14 -0500 | Rating Details | |
| 2024-04-16 23:50:54 -0500 | Rating Details | |
| 2024-04-16 23:42:29 -0500 | Rating Details | |
| 2024-04-16 23:40:17 -0500 | Rating Details | |
| 2024-04-16 23:23:55 -0500 | Rating Details | |
| 2024-04-16 23:15:03 -0500 | Rating Details | |
| 2024-04-27 07:29:10 -0500 | Rating Details | |
| 2024-04-17 08:40:18 -0500 | Rating Details | |
| 2024-04-17 05:00:55 -0500 | Rating Details | |
| 2024-04-17 04:55:42 -0500 | Rating Details | |
| 2024-04-17 04:39:04 -0500 | Rating Details | |
| 2024-04-17 04:33:51 -0500 | Rating Details | |
| 2024-04-17 04:24:12 -0500 | Rating Details | |
| 2024-04-17 04:01:22 -0500 | Rating Details | |
| 2024-04-17 03:48:22 -0500 | Rating Details | |
| 2024-04-17 03:29:41 -0500 | Rating Details | |
| 2024-04-17 03:12:18 -0500 | Rating Details | |
| 2024-04-17 03:11:05 -0500 | Rating Details | |
| 2024-04-17 02:52:55 -0500 | Rating Details | |
| 2024-04-17 02:50:30 -0500 | Rating Details | |
| 2024-04-17 02:35:47 -0500 | Rating Details | |
| 2024-04-17 02:35:30 -0500 | Rating Details | |
| 2024-04-17 02:31:04 -0500 | Rating Details | |
| 2024-04-17 02:30:52 -0500 | Rating Details | |
| 2024-04-17 02:27:22 -0500 | Rating Details | |
| 2024-04-17 02:22:36 -0500 | Rating Details | |
| 2024-04-17 02:19:56 -0500 | Rating Details | |
| 2024-04-17 02:16:32 -0500 | Rating Details | |
| 2024-04-17 02:02:28 -0500 | Rating Details | |
| 2024-04-17 01:39:33 -0500 | Rating Details | |
| 2024-04-17 00:53:14 -0500 | Rating Details | |
| 2024-04-17 00:43:53 -0500 | Rating Details | |
| 2024-04-17 00:40:01 -0500 | Rating Details | |
| 2024-04-17 00:07:18 -0500 | Rating Details | |
| 2024-04-17 00:03:46 -0500 | Rating Details | |
| 2024-04-16 23:56:44 -0500 | Rating Details | |
| 2024-04-16 23:44:55 -0500 | Rating Details | |
| 2024-04-16 23:38:49 -0500 | Rating Details |